AVR insider trading

Healthcare

Anteris Technologies Global Corp.: insider trade history from SEC Form 4 filings.

Total Form 4 trades
46
Last 90 days
19
Buys / sells
15% / 28%
Market cap
$548.17M

About Anteris Technologies Global Corp.

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

Company website: anteristech.com

AVR insider activity at a glance

FilingIQ tracks 46 insider transactions for AVR in filings since Dec 18, 2024. The most recent transaction is dated Oct 5, 2026.

Across the full history, 7 open-market purchases and 13 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on AVR insider trades is 49.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest AVR Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for AVR?
FilingIQ tracks 46 Form 4 insider transactions for AVR (Anteris Technologies Global Corp.), covering filings from Dec 18, 2024 onwards. 19 of those are dated within the last 90 days.
Are AVR insiders net buyers or net sellers?
Across the full Form 4 history for AVR, 7 transactions (15%) were open-market purchases and 13 (28%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does AVR insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is AVR in?
Anteris Technologies Global Corp. (AVR) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $548.17M.

Methodology & sources

Every AVR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.